Overview and Scope
A migraine is a neurological disorder characterized by recurring episodes of severe and debilitating headache, often accompanied by other symptoms such as nausea, vomiting, sensitivity to light (photophobia) and sensitivity to sound (phonophobia). Migraines are typically one-sided and throbbing and can last a few hours to several days. Treating migraines involves a combination of approaches aimed at relieving the immediate symptoms during an attack and preventing future migraine episodes.
Sizing and Forecast
The migraine market size has grown steadily in recent years. It will grow from $1.87 billion in 2023 to $1.93 billion in 2024 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to increasing prevalence of migraines, growing awareness about migraine treatment, government initiatives, increasing prevalence of alcohol consumption, shifts in lifestyle.
The migraine market size is expected to see steady growth in the next few years. It will grow to $2.15 billion in 2028 at a compound annual growth rate (CAGR) of 2.8%. The growth in the forecast period can be attributed to adoption of combination therapies, growing number of screening programs for migraines, increasing prevalence of smoking habits, awareness of the importance of lifestyle management for migraine. Major trends in the forecast period include innovative treatments for migraines, development of targeted therapies for migraines, advancements in diagnosis and treatment of migraines, digital health technologies for migraine management.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/migraine-global-market-report
Segmentation & Regional Insights
The migraine market covered in this report is segmented –
1) By Type: Episodic; Chronic
2) By Treatment: Preventive; Abortive
3) By Drug Class: Triptans; Ergots; Other Drug Classes
North America was the largest region in the migraine market in 2023. The regions covered in migraine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12919&type=smp
Major Driver Impacting Market Growth
The increase in the prevalence of migraine is expected to propel the growth of the migraine market going forward. A migraine is a type of headache that typically affects one side of the brain and produces excruciating throbbing pain or a pulsing sensation. Migraine treatment offers numerous benefits for managing and alleviating the symptoms of migraines by relieving the pain, with improved functionality, reduced frequency and severity, enhanced productivity and quality of life of the people suffering from migraine. For instance, in January 2023, according to Nature Reviews Neurology, a UK-based journal website, globally, the current estimated prevalence of migraine is 14- 15%, accounting for 4.9% of the global population ill health quantified in years (actual year) with disability (YLDs). Therefore, the increase in the prevalence of migraine drives the migraine market.
Key Industry Players
Major players in the migraine market are Pfizer Inc., Johnson and Johnson Limited, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Co Ltd., Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Almirall S.A., Lannett Company Inc., Wockhardt Limited.
The migraine market report table of contents includes:
1. Executive Summary
2.Migraine Market Characteristics
3.Migraine Market Trends And Strategies
4.Migraine Market analysis
5.Migraine Market Size And Growth
6. Migraine Segmentation
7. Migraine Regional And Country Analysis
.
.
.
27.Migraine Migraine Competitive Landscape And Company Profiles
28.Migraine Key Mergers And Acquisitions
29.Migraine Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Pfizer Inc.
- Johnson and Johnson Limited
- Merck & Co. Inc.
- Bayer AG
- Novartis AG
- Sanofi-Aventis LLC.
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
